Publications

Real-Life Data on First- and Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer With Abiraterone, Enzalutamide and Cabazitaxel - A Multicentric Study From Portugal

AuthID
P-016-VCV

Author(s)

Botelho, F

Braga, I

Leao, R

Teves, F

Dias, J

Rodrigues, F

Oliveira, J

Augusto, I

Portela, C

Febra, J

Custódio, S

Liu, PTC

Gago, P

Miranda, A

Silva, C

Pacheco-Figueiredo, L

Document Type

Article

Year published

2024

Published

in CLINICAL GENITOURINARY CANCER, ISSN: 1558-7673

Volume: 22, Issue: 6

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.clgc.2024.102169

Pubmed: 39153249

SCOPUS: 2-s2.0-85201261265

Wos: WOS:001306616500001

Source Identifiers

ISSN: 1558-7673

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Real-Life Data on First- and Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer With Abiraterone, Enzalutamide and Cabazitaxel - A Multicentric Study From Portugal

Useful Links

Get Help

Federated Authentication (Click on the image)

Real-Life Data on First- and Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer With Abiraterone, Enzalutamide and Cabazitaxel - A Multicentric Study From Portugal

Useful Links

Get Help